04:01 PM EST, 02/07/2025 (MT Newswires) -- (Updates with the lender in the first paragraph.)

Entero Therapeutics ( ENTO ) got a $2 million revolving loan and appointed three new board members designated by the lender, 1396974 BC Ltd., as a condition for the funding.

Richard Paolone, Eric Corbett and Manpreet Uppal replaced James Sapirstein, Alastair Riddell and Timothy Ramdeen on the board, the company said in a regulatory filing dated Thursday.

The board has five members. Sapirstein is chief executive officer of Entero.

Price: 0.56, Change: +0.03, Percent Change: +6.44